Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 12/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 11/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 8/20 | 0.42 |
| ▸ | HTR2A | P28223 | 4/20 | 0.42 |
| ▸ | HTR2B | P41595 | 2/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | HTR3A | P46098 | 1/20 | 0.34 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.33 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL597741 | 0.90 | ADRA2C (0.41) | ADRA2CSLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL599223 | 0.90 | ADRA2C (0.41) | ADRA2CSLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL950714 | 0.87 | ADRA2C (0.40) | ADRA2CSLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL27767545 | 0.86 | ADRA2C (0.41) | ADRA2CSLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL6008849 | 0.84 | SLC6A2 (0.41) | ADRA2CSLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL14889216 | 0.83 | ADRA2C (0.40) | ADRA2CSLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL10330624 | 0.81 | SLC6A2 (0.47) | ADRA2CSLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL1746181 | 0.81 | SLC6A2 (0.42) | ADRA2CSLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL13745152 | 0.81 | SLC6A2 (0.39) | ADRA2CSLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL14275280 | 0.80 | SLC6A4 (0.39) | ADRA2CSLC6A2SLC6A4SLC6A3HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109456704-B | Metal Chemical Mechanical Planarization (CMP) compositions and methods thereof | 弗萨姆材料美国有限责任公司 | 2021-08-27 | — | — | CN | disclosed |
| US-10920106-B2 | Metal chemical mechanical planarization (CMP) composition and methods therefore | VERSUM MATERIALS US, LLC (US) | 2021-02-16 | — | — | US | disclosed |
| US-20200032107-A1 | Metal Chemical Mechanical Planarization (CMP) Composition And Methods Therefore | VERSUM MATERIALS US, LLC (US) | 2020-01-30 | — | — | US | disclosed |
| US-10465096-B2 | Metal chemical mechanical planarization (CMP) composition and methods therefore | VERSUM MATERIALS US, LLC (US) | 2019-11-05 | — | — | US | disclosed |
| CN-109456704-A | Metal chemical mechanical planarization (CMP) compositions and methods thereof | 弗萨姆材料美国有限责任公司 | 2019-03-12 | — | — | CN | disclosed |
| CN-105037382-B | Bergenin analog derivative and its preparation method and application | 中国药科大学 | 2017-08-25 | — | — | CN | disclosed |
| CN-105037382-A | Bergenin derivatives, and preparation method and application thereof | UNIV CHINA PHARMA | 2015-11-11 | — | — | CN | disclosed |
| EP-1885187-B1 | METHODS FOR TREATING DRUG RESISTANT CANCER | NOVARTIS AG (CH) | 2013-09-25 | — | — | EP | disclosed |
| WO-2013000924-A1 | 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES | JANSSEN PHARMACEUTICA NV (BE) | 2013-01-03 | — | — | WO | disclosed |
| CN-102694205-A | Electrolyte solvent and electrolyte solution for lithium oxysalt anode active substance, and lithium ion secondary cell | SHOEI CHEMICAL IND CO | 2012-09-26 | — | — | CN | disclosed |
| EP-0935625-A1 | RIGID POLYURETHANE FOAMS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1999-08-18 | — | — | EP | disclosed |
| WO-1998020059-A1 | RIGID POLYURETHANE FOAMS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1998-05-14 | — | — | WO | disclosed |